Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension

by Habib Bouzina, Roger Hesselstrand, Göran Rådegran
Published 2019-12-01

Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study

by Bodil Ivarsson, Göran Rådegran, Roger Hesselstrand, Barbro Kjellström
Published 2018-01-01

Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension

by Bodil Ivarsson, Trygve Sjöberg, Roger Hesselstrand, Göran Rådegran, Barbro Kjellström
Published 2019-02-01

Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension

by Mattias Arvidsson, Abdulla Ahmed, Joanna Säleby, Roger Hesselstrand, Göran Rådegran
Published 2022-01-01

Perceptions of Received Information, Social Support, and Coping in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

by Bodil Ivarsson, Björn Ekmehag, Roger Hesselstrand, Göran Rådegran, Trygve Sjöberg
Published 2014-10-01

Perceptions of Received Information, Social Support, and Coping in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

by Bodil Ivarsson, Björn Ekmehag, Roger Hesselstrand, Goran Radegran, Trygve Sjöberg
Published 2014-01-01

Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls

by Ellen Tufvesson, Erik Nilsson, Todor A. Popov, Roger Hesselstrand, Leif Bjermer
Published 2020-01-01

Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension

by Mattias Arvidsson, Abdulla Ahmed, Joanna Säleby, Salaheldin Ahmed, Roger Hesselstrand, Göran Rådegran
Published 2023-07-01

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study

by Kristofer Andréasson, Karl Neringer, Dirk M. Wuttge, Dan Henrohn, Jan Marsal, Roger Hesselstrand
Published 2020-10-01

Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study

by Tom Gyllenhammar, Mikael Kanski, Henrik Engblom, Dirk M. Wuttge, Marcus Carlsson, Roger Hesselstrand, Håkan Arheden
Published 2018-01-01

Predicting mortality during long-term follow-up in pulmonary arterial hypertension

by David Kylhammar, Clara Hjalmarsson, Roger Hesselstrand, Kjell Jansson, Mohammad Kavianipour, Barbro Kjellström, Magnus Nisell, Stefan Söderberg, Göran Rådegran
Published 2021-05-01

Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a re...

by Clara Hjalmarsson, Oisin Butler, Roger Hesselstrand, Katsiaryna Holl, Kjell Jansson, Rogier Klok, Göran Rådegran, Stefan Söderberg, Barbro Kjellström
Published 2020-09-01

Longitudinal changes in risk status in pulmonary arterial hypertension

by Habib Bouzina, Göran Rådegran, Oisin Butler, Roger Hesselstrand, Clara Hjalmarsson, Katsiaryna Holl, Kjell Jansson, Rogier Klok, Stefan Söderberg, Barbro Kjellström
Published 2021-02-01

N-Formyl Methionine Peptide-Mediated Neutrophil Activation in Systemic Sclerosis

by Runa Kuley, Ryan D. Stultz, Bhargavi Duvvuri, Ting Wang, Marvin J. Fritzler, Roger Hesselstrand, J Lee Nelson, J Lee Nelson, Christian Lood
Published 2022-01-01

Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren’s syndrom...

by Andreas Jönsen, Örjan Dahlström, Roger Hesselstrand, Christopher Sjöwall, Kristofer Andréasson, Per Eriksson, Anders A Bengtsson, Lina Wirestam, Charlotte Dahle, Rama Andraos, Awais Ahmad
Published 2022-08-01

Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts

by Kristofer Andréasson, S. Melanie Lee, Venu Lagishetty, Meifang Wu, Natalie Howlett, James English, Roger Hesselstrand, Philip J. Clements, Jonathan P. Jacobs, Elizabeth R. Volkmann
Published 2022-05-01

Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment

by Clara Hjalmarsson, Barbro Kjellström, Kjell Jansson, Magnus Nisell, David Kylhammar, Mohammad Kavianipour, Göran Rådegran, Stefan Söderberg, Gerhard Wikström, Dirk M. Wuttge, Roger Hesselstrand
Published 2021-08-01

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study

by Viggo Hamberg, Azita Sohrabian, Elizabeth R. Volkmann, Marie Wildt, Anna Löfdahl, Dirk M. Wuttge, Roger Hesselstrand, Göran Dellgren, Gunilla Westergren-Thorsson, Johan Rönnelid, Kristofer Andréasson
Published 2023-09-01

The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes.

by Timothy R D J Radstake, Lenny van Bon, Jasper Broen, Anila Hussiani, Roger Hesselstrand, Dirk M Wuttge, Yanhui Deng, Robbert Simms, Erik Lubberts, Robert Lafyatis
Published 2009-06-01

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

by Roger Hesselstrand, Jörg H. W. Distler, Gabriela Riemekasten, Dirk M. Wuttge, Marie Törngren, Helén C. Nyhlén, Fredrik Andersson, Helena Eriksson, Birgitta Sparre, Helén Tuvesson, Oliver Distler
Published 2021-07-01